Abstract Background In December 2019, a novel coronavirus disease (COVID-19) emerged
in Wuhan, China, with an incredible contagion rate. However, the vertical transmission of …

Background COVID-19, the coronavirus disease that emerged in December 2019, caused
drastic damage worldwide. At the beginning of the pandemic, available data suggested that …

Background Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak,
there has been an increasing interest in finding a potential therapeutic agent for the disease …

Pandemics are enormous threats to the world that impact all aspects of our lives, especially
the global economy. The COVID-19 pandemic has emerged since December 2019 and has …

Background Data on immune responses to SARS-CoV-2 in patients with Primary Antibody
Deficiencies (PAD) are limited to infected patients and to heterogeneous cohorts after …

Research on coronavirus disease 2019 vaccination in immune-deficient/disordered people
(IDP) has focused on cancer and organ transplantation populations. In a prospective cohort …

A better understanding of COVID-19 in people with primary immunodeficiency (PI), rare
inherited defects in the immune system, is important for protecting this population, especially …

Introduction Patients with inborn errors of immunity (IEI) have a compromised or
inappropriate immune response. Although they might be considered a high-risk group for …

CVID patients have an increased susceptibility to vaccine-preventable infections. The
question on the potential benefits of immunization of CVID patients against SARS-CoV-2 …

Coronavirus disease 2019 (COVID-19) has spread rapidly and become a pandemic.
Caused by a novel human coronavirus called severe acute respiratory syndrome …